News & Events

News

Lessons from a professor's 10-year fight to to rein in pharmaceutical promotion. Dr. Carl Elliott, Center for Bioethics, is mentioned. The Chronicle of Higher Education.

Read more...
How GOP secrecy on the health bill plays into our psychological biases. Dr. Sarah Gollust, School of Public Health, is quoted. Vox.
 
Read more...
Gender Policy article DeBruin

Gender Transition Healthcare Services Under The Trump Administration.  This piece was written as part of the course “Gender and the Politics of Health” taught by Debra DeBruin, PhD, Associate Professor, Center for Bioethics, Department of Medicine, and College of Liberal Arts Department of Philosophy, University of Minnesota. Author: Sajya Singh, Undergraduate Student, Department of Genetics, Cell Biology, and Development, University of Minnesota

Read more...
Compound Solutions by Susan Craddock
Craddock S. Compound Solutions: Pharmaceutical Alternatives for Global Health. University of Minnesota Press 2017.

An unparalleled, interdisciplinary analysis, 
Compound Solutions examines Product Development Partnerships (PDPs), which arose early in the twenty-first century to develop new drugs and vaccines for infectious diseases in low-...
Read more...
Journal of Ethics Header

What Should Physicians Do When They Disagree, Clinically and Ethically, with a Surrogate’s Wishes? alumnus Terri Traudt and faculty member Joan Liaschenko have co-authored.  The AMA Journal of Ethics:

Read more...

Pages

Upcoming events

Jon Merz, MBA, JD, PhD
Thursday, June 29, 2017 -
12:15pm to 1:30pm

2-520 Moos Tower, U of M East Bank Campus

Is There a Legal Privilege to Waive Consent for Research?

Presented by: Jon Merz, MBA, JD, PhD
Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania

Waivers of informed consent for research participation are permitted under the Common Rule as well as the Exception from Informed Consent (EFIC) for emergency research rule. We examine waivers as embodiments of legal privilege, which permit actors to violate legal norms in furtherance of greater social goods. The emergency privilege, which allows a caregiver to provide emergency medical care to an incompetent victim of an accident, is the clearest example. But fundamental to the privilege to acting without consent is the presumption that reasonable persons in the patients' position would agree, if capable, and that no evidence exists that the particular patient would not agree. An assessment of what is known about participation and refusal rates in research show that the presumption with respect to standard care is not applicable to research. This suggests that, while researchers may assert the social utility of their studies are high enough to justify waivers,there is reason to suspect that many who would be enrolled under a waiver of consent would not want to be enrolled.Our analysis suggests that waivers should be rare, IRBs and researchers must explicitly address study acceptability, and it should be incumbent upon researchers to establish by clear, sound evidence that proposed studies would be acceptable in the community at large and the target population.

Seminars are free and open to the public.

Jochen Vollmann
Friday, July 21, 2017 -
12:45pm to 2:00pm

5-125 Moos Tower, U of M East Bank campus

Palliative Care Exceptionalism? A Broader Perspective on End of Life Care and Modern Medicine

Presented by:  Jochen Vollmann, MD, PhD
Professor, Medical Ethics, Director, Institute for Medical Ethics and History of Medicine, and President, Center for Medical Ethics, Ruhr University Bochum, Germany

Palliative care is an innovative and growing field focussing on life-threatening illness and on the relief of suffering by means of early identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual. In this “holistic” approach palliative care differs from science based modern medicine and shows similarities to other “holistic” approaches to the patient as a subject as well as to pre-modern medicine. Professor Vollmann discusses from his ongoing research palliative care exceptionalism and a broader perspective on end of life care and modern medicine and its’ consequences for future health care.

Seminars are free and open to the public.